Loading…

MAGOH promotes gastric cancer progression via hnRNPA1 expression inhibition-mediated RON[DELA]160/PI3K/AKT signaling pathway activation

Background Gastric cancer (GC) is associated with high mortality and heterogeneity and poses a great threat to humans. Gene therapies for the receptor tyrosine kinase RON and its spliceosomes are attracting increasing amounts of attention due to their unique characteristics. However, little is known...

Full description

Saved in:
Bibliographic Details
Published in:Journal of experimental & clinical cancer research 2024-01, Vol.43 (1)
Main Authors: Yu, Shanshan, Chen, Cheng, Chen, Ming, Liang, Jinxiao, Jiang, Kecheng, Lou, Bin, Lu, Jun, Zhu, Xiaohua, Zhou, Donghui
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Gastric cancer (GC) is associated with high mortality and heterogeneity and poses a great threat to humans. Gene therapies for the receptor tyrosine kinase RON and its spliceosomes are attracting increasing amounts of attention due to their unique characteristics. However, little is known about the mechanism involved in the formation of the RON mRNA alternative spliceosome RON[DELA]160. Methods Fourteen human GC tissue samples and six normal gastric tissue samples were subjected to label-free relative quantitative proteomics analysis, and MAGOH was identified as a candidate protein for subsequent studies. The expression of MAGOH in clinical specimens was verified by quantitative real-time PCR and western blotting. We then determined the biological function of MAGOH in GC through in vitro and in vivo experiments. RNA pulldown, RNA sequencing and RNA immunoprecipitation (RIP) were subsequently conducted to uncover the underlying mechanism by which MAGOH regulated the formation of RON[DELA]160. Results Proteomic analysis revealed that MAGOH, which is located at key nodes and participates in RNA processing and mRNA splicing, was upregulated in GC tissue and GC cell lines and was associated with poor prognosis. Functional analysis showed that MAGOH promoted the proliferation, migration and invasion of GC cells in vitro and in vivo. Mechanistically, MAGOH inhibited the expression of hnRNPA1 and reduced the binding of hnRNPA1 to RON mRNA, thereby promoting the formation of RON[DELA]160 to activate the PI3K/AKT signaling pathway and consequently facilitating GC progression. Conclusions Our study revealed that MAGOH could promote the formation of RON[DELA]160 and activate the PI3K/AKT signaling pathway through the inhibition of hnRNPA1 expression. We elucidate a novel mechanism and potential therapeutic targets for the growth and metastasis of GC based on the MAGOH-RON[DELA]160 axis, and these findings have important guiding significance and clinical value for the future development of effective therapeutic strategies for GC. Keywords: Gastric cancer, MAGOH, RON[DELA]160, hnRNPA1, Alternative splicing, PI3K/AKT signaling pathway
ISSN:0392-9078
DOI:10.1186/s13046-024-02946-8